Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in some content.SummaryDifference1%

- Check7 days agoChange DetectedThe site's footer revision identifier updates from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a new Revision: v3.7.0 tag. A large set of study documents and related entries (e.g., Statistical Analysis Plan, Study Protocol, IPD plans, and provider details) were removed from the Study Documents section, changing the accessibility of key materials for the trial.SummaryDifference18%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a new version of the page rather than substantive changes to study information.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page's revision label updates from v3.6.4 to v3.6.5, reflecting a new release version. This change signals an updated page version but does not modify the study details or main content displayed on the page.SummaryDifference0.0%

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.